Abstract:BackgroundNon-polio-enteroviruses (EV) and human parechoviruses (HPeV) are small RNA viruses, which in newborns cause infections with a wide range of severity. Today molecular biology tools allow us to diagnose viral meningitis in neonates, sparing patients from useless antibiotics. Data on neurodevelopmental outcome of children who contract enterovirus meningitis in early childhood are still limited in the literature.AimsTo evaluate the neurodevelopmental outcome of newborns with documented enterovirus and pa… Show more
“…and HpEV are major causes of infection in children and may present with a variety of clinical manifestations [1][2][3][4]6]. In neonates and young infants, EV and HpEV have been reported to cause sepsis-like illnesses and severe CNS infections.…”
Section: Discussionmentioning
confidence: 99%
“…In neonates and young infants, EV and HpEV have been reported to cause sepsis-like illnesses and severe CNS infections. It has been reported that the younger the patient, the more severe the clinical manifestations [2,4,6,7].…”
Section: Discussionmentioning
confidence: 99%
“…Poliomyelitis is the most widely described example of a disease caused by an EV, but with the introduction of anti-polio vaccines in the 1950s, it has been almost eradicated [2]. The decrease in poliomyelitis has increased the recognition of the infection burden of the non-polio EV and HpEV, which share with poliovirus a characteristic central nervous system (CNS) tropism [1][2][3][4][5].…”
Section: Introductionmentioning
confidence: 99%
“…EV and HpEV infections are observed in all age groups, but mainly in children below one year of age [1,2,4]. Although infections in children are mostly asymptomatic or associated with mild disease, both EV and HpEV are particularly fearful in newborns because of the immaturity of their immune systems.…”
Section: Introductionmentioning
confidence: 99%
“…Although infections in children are mostly asymptomatic or associated with mild disease, both EV and HpEV are particularly fearful in newborns because of the immaturity of their immune systems. In this age group, severe and sometimes fatal conditions can be observed, including aseptic meningitis, encephalitis, myocarditis, and acute hepatitis [2,4,6,7]. These viruses may represent up to 20% of non-bacterial neonatal sepsis, although there is still a lack of their real incidence and impact on the pediatric population, especially in newborns [8].…”
Purpose
Parechoviruses (HpEV) and Enteroviruses (EV) infections in children mostly have a mild course but are particularly fearsome in newborns in whom they may cause aseptic meningitis, encephalitis, and myocarditis. Our study aimed to describe the clinical presentations and peculiarities of CNS infection by HpEV and EV in neonates.
Methods
Single-center retrospective study at Istituto Gaslini, Genoa, Italy. Infants aged ≤30 days with a CSF RTq-PCR positive for EV or HpEV from January 1, 2022, to December 1, 2023, were enrolled. Each patient's record included demographic data, blood and CSF tests, brain MRI, therapies, length of stay, ICU admission, complications, and mortality. The two groups were compared to identify any differences and similarities.
Results
Twenty-five patients (15 EV and 10 HpEV) with a median age of 15 days were included. EV patients had more comorbidities (p=0.021), more respiratory symptoms (p=0.012), and higher C-reactive protein (CRP) levels on admission (p=0.027), whereas ferritin values were significantly increased in HpEV patients (p=0.001). Eight patients had a pathological brain MRI, equally distributed between the two groups. Three EV patients developed myocarditis and one HpEV necrotizing enterocolitis with HLH-like. No deaths occurred.
Conclusions
EV and HpEV CNS infections are not easily distinguishable by clinical features. In both cases, brain MRI abnormalities are not uncommon and a severe course of the disease is possible. Hyper-ferritinemia may represent an additional diagnostic clue for HpEV infection and its monitoring is recommended to intercept HLH early and initiate immunomodulatory treatment. Larger studies are needed to confirm our findings.
“…and HpEV are major causes of infection in children and may present with a variety of clinical manifestations [1][2][3][4]6]. In neonates and young infants, EV and HpEV have been reported to cause sepsis-like illnesses and severe CNS infections.…”
Section: Discussionmentioning
confidence: 99%
“…In neonates and young infants, EV and HpEV have been reported to cause sepsis-like illnesses and severe CNS infections. It has been reported that the younger the patient, the more severe the clinical manifestations [2,4,6,7].…”
Section: Discussionmentioning
confidence: 99%
“…Poliomyelitis is the most widely described example of a disease caused by an EV, but with the introduction of anti-polio vaccines in the 1950s, it has been almost eradicated [2]. The decrease in poliomyelitis has increased the recognition of the infection burden of the non-polio EV and HpEV, which share with poliovirus a characteristic central nervous system (CNS) tropism [1][2][3][4][5].…”
Section: Introductionmentioning
confidence: 99%
“…EV and HpEV infections are observed in all age groups, but mainly in children below one year of age [1,2,4]. Although infections in children are mostly asymptomatic or associated with mild disease, both EV and HpEV are particularly fearful in newborns because of the immaturity of their immune systems.…”
Section: Introductionmentioning
confidence: 99%
“…Although infections in children are mostly asymptomatic or associated with mild disease, both EV and HpEV are particularly fearful in newborns because of the immaturity of their immune systems. In this age group, severe and sometimes fatal conditions can be observed, including aseptic meningitis, encephalitis, myocarditis, and acute hepatitis [2,4,6,7]. These viruses may represent up to 20% of non-bacterial neonatal sepsis, although there is still a lack of their real incidence and impact on the pediatric population, especially in newborns [8].…”
Purpose
Parechoviruses (HpEV) and Enteroviruses (EV) infections in children mostly have a mild course but are particularly fearsome in newborns in whom they may cause aseptic meningitis, encephalitis, and myocarditis. Our study aimed to describe the clinical presentations and peculiarities of CNS infection by HpEV and EV in neonates.
Methods
Single-center retrospective study at Istituto Gaslini, Genoa, Italy. Infants aged ≤30 days with a CSF RTq-PCR positive for EV or HpEV from January 1, 2022, to December 1, 2023, were enrolled. Each patient's record included demographic data, blood and CSF tests, brain MRI, therapies, length of stay, ICU admission, complications, and mortality. The two groups were compared to identify any differences and similarities.
Results
Twenty-five patients (15 EV and 10 HpEV) with a median age of 15 days were included. EV patients had more comorbidities (p=0.021), more respiratory symptoms (p=0.012), and higher C-reactive protein (CRP) levels on admission (p=0.027), whereas ferritin values were significantly increased in HpEV patients (p=0.001). Eight patients had a pathological brain MRI, equally distributed between the two groups. Three EV patients developed myocarditis and one HpEV necrotizing enterocolitis with HLH-like. No deaths occurred.
Conclusions
EV and HpEV CNS infections are not easily distinguishable by clinical features. In both cases, brain MRI abnormalities are not uncommon and a severe course of the disease is possible. Hyper-ferritinemia may represent an additional diagnostic clue for HpEV infection and its monitoring is recommended to intercept HLH early and initiate immunomodulatory treatment. Larger studies are needed to confirm our findings.
Enterovirus (EV) infections have various symptoms and severe complications, including death. To determine EV prevalence and EV types in Slovenia, data on over 25 000 EV RNA tests for diagnostics and surveillance from 2014 to 2023 were analyzed. Altogether, 3733 cerebrospinal fluid (CSF) and 21 297 respiratory (sentinel and clinical) samples were tested for EV RNA. EV typing was performed on all residual EV‐positive CSF samples and on subset of respiratory specimens. Altogether, 1238 samples tested positive for EV RNA: 238 (6.4%) CSF and 1000 (4.7%) respiratory samples. EV‐positive patients were predominantly male (p < 0.001). Many EV‐positive CSF samples were from infants under 3 months (33.1%), whereas most EV‐positive respiratory samples were from children 1 to 2 years old (49.2%). Echovirus 30 (E‐30) was most frequent in CSF (33.0%), followed by CV‐B5 (13.8%) and E‐6 (13.8%). CV‐A6 was most frequent in respiratory samples (16.0%), followed by EV‐D68 (7.6%) and CV‐A5 (7.4%). EV types in CSF and respiratory samples show diverse dynamics, with some outbreaks indicated. A significant difference was found in the EV detection rate between CSF and respiratory samples by age. Various EV types were characterized, showing that some EV types are more neurotropic or cause more severe infections.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.